The study included 68 pregnant women, 38 of whom became infected with COVID-19 during their third trimester prior to the development of the vaccine. The remaining 30 subjects were healthy pregnant women who tested negative for COVID-19. Half the fetuses were male and half were female in both groups.
Key takeaways:
- The placentas of male fetuses carried by women with COVID-19 had much higher expression of interferon-stimulated genes.
- Mothers with COVID-19 carrying male fetuses make lower levels of antibodies against the virus than those carrying female fetuses.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
